EyePoint Pharmaceuticals, Inc. — Director's Dealing 2015

Jul 27, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2015-07-23

Reporting Person: Ross Leonard S (Vice President, Finance)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-23	Employee Stock Option (right to buy)	$4.09	A	40000	Acquired	2025-07-23	Common Stock (40000)	Direct

Footnotes

F1: The option becomes exercisable in four equal annual installments beginning on the first anniversary of the date of grant.